CRTPF - Cardiol Therapeutics names ex-Amgen executive as medical chief
Cardiol Therapeutics (CRTPF) appointed 30-years industry veteran Dr. Andrew Hamer as chief medical officer, effective immediately, leading the R&D of the company's clinical-stage products and also guiding the development of additional novel therapeutics in the company's pipeline.Retiring CMO and co-founder of Cardiol, Dr. Eldon Smith, will continue to serve as chair of the board and as an board advisor.Most recently, he served as Executive Director, Global Development-Cardiometabolic at California-based Amgen.
For further details see:
Cardiol Therapeutics names ex-Amgen executive as medical chief